Protalix BioTherapeutics Company Profile (NYSE:PLX)

About Protalix BioTherapeutics

Protalix BioTherapeutics logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: PLX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.62
  • 50 Day Moving Average: $0.6422
  • 200 Day Moving Average: $0.7674
  • Trailing P/E Ratio: 1.2182
  • Foreward P/E Ratio: -1.97
  • P/E Growth: -0.0700
  • Market Cap: $61.49M
  • Outstanding Shares: 99,758,000
Additional Links:

Analyst Ratings

Consensus Ratings for Protalix BioTherapeutics (NYSE:PLX) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Protalix BioTherapeutics (NYSE:PLX)
Show:
DateFirmActionRatingPrice TargetDetails
7/11/2016Rodman & RenshawReiterated RatingBuyView Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Protalix BioTherapeutics (NYSE:PLX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q2 16($0.08)($0.11)$1.34 million$1.77 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Protalix BioTherapeutics (NYSE:PLX)
Current Year EPS Consensus Estimate: $-0.36 EPS
Next Year EPS Consensus Estimate: $-0.31 EPS

Dividends

Dividend History for Protalix BioTherapeutics (NYSE:PLX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Protalix BioTherapeutics (NYSE:PLX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Protalix BioTherapeutics (NYSE:PLX)
DateHeadline
rttnews.com logoProtalix Reports Addl. Positive Data From Phase I/II Fabry Clinical Trial (NYSE:PLX)
www.rttnews.com - August 10 at 9:58 AM
streetinsider.com logoProtalix BioTherapeutics (PLX) Issues Positive Update on PRX-102 Phase I/II; Improvements of Stabilization Noted (NYSE:PLX)
www.streetinsider.com - August 10 at 9:58 AM
publicnow.com logoProtalix BioTherapeutics Announces Additional Positive Data from its Phase I/II Clinical Trial for PRX-102 for the Treatment of Fabry Disease (NYSE:PLX)
www.publicnow.com - August 10 at 9:58 AM
News IconNext Weeks Broker Price Targets For Protalix BioTherapeutics, Inc. (PLX) - Share Trading News (NYSE:PLX)
www.sharetrading.news - May 23 at 12:38 AM
marketwatch.com logoThe Plaque Psoriasis (Psoriasis Vulgaris) Pipeline 2016 Market Report - MarketWatch (NYSE:PLX)
www.marketwatch.com - May 20 at 8:03 PM
News IconBroker Roundup For Protalix BioTherapeutics, Inc. (PLX) - Share Trading News (NYSE:PLX)
www.sharetrading.news - May 20 at 8:03 PM
capitalcube.com logoProtalix Biotherapeutics, Inc. :PLX-US: Earnings Analysis: Q1, 2016 By the Numbers : May 19, 2016 (NYSE:PLX)
www.capitalcube.com - May 19 at 2:54 AM
News IconProtalix BioTherapeutics Inc. Formed a Bearish Double Bottom, Could Be One of The Worst Performers Going Forward - Wall Street Hints and News (NYSE:PLX)
hintsnewsnetwork.com - May 19 at 1:19 AM
capitalcube.com logoProtalix Biotherapeutics, Inc. :PLX-US: Earnings Analysis: Q1, 2016 By the Numbers (NYSE:PLX)
www.capitalcube.com - May 17 at 1:20 PM
sg.finance.yahoo.com logoProtalix reports 1Q loss (NYSE:PLX)
sg.finance.yahoo.com - May 9 at 7:59 AM
publicnow.com logoProtalix BioTherapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update (NYSE:PLX)
www.publicnow.com - May 9 at 7:16 AM
News IconBroker Outlook For The Week Ahead Protalix BioTherapeutics, Inc. (PLX) - Share Trading News (NYSE:PLX)
www.sharetrading.news - May 9 at 3:40 AM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Sellers Covered 11.98% of Their Shorts - B.O.D.Y Confidential (NYSE:PLX)
www.bodyconfidential.com - May 7 at 7:36 PM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Shorted Shares Decreased By 1.53% - B.O.D.Y Confidential (NYSE:PLX)
www.bodyconfidential.com - April 28 at 2:50 AM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Shorts Decreased by 1.53% After Short Covering - B.O.D.Y Confidential (NYSE:PLX)
www.bodyconfidential.com - April 22 at 10:37 PM
News IconLatest Analyst Ratings For Protalix BioTherapeutics, Inc. (PLX) - Share Trading News (NYSE:PLX)
www.sharetrading.news - April 19 at 10:36 PM
News IconBroker Outlook For Protalix BioTherapeutics, Inc. (PLX) - Share Trading News (NYSE:PLX)
www.sharetrading.news - April 14 at 10:53 PM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Sellers Covered 6.08% of Their Shorts - Stock Caller (NYSE:PLX)
www.stockcaller.com - April 14 at 2:46 AM
News IconProtalix BioTherapeutics, Inc. (PLX) Latest Broker Views - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - April 12 at 9:57 PM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Shorted Shares Decreased By 6.08% - RiversideGazette.com (NYSE:PLX)
www.riversidegazette.com - April 9 at 4:02 AM
News IconProtalix BioTherapeutics, Inc. (PLX) Analyst Review - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - April 8 at 10:53 PM
biz.yahoo.com logoPROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events (NYSE:PLX)
biz.yahoo.com - April 8 at 5:01 PM
News IconProtalix BioTherapeutics, Inc. (PLX) Latest Broker Coverage - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - April 5 at 9:24 PM
finance.yahoo.com logoCoverage initiated on Protalix BioTherapeutics by Rodman & Renshaw (NYSE:PLX)
finance.yahoo.com - April 4 at 7:06 AM
News IconMenora Mivtachim Holdings Ltd. Lowers stake in Protalix BioTherapeutics (PLX) - Street Edition (NYSE:PLX)
www.streetedition.net - April 2 at 8:35 PM
News IconUpgrades And Downgrades For Protalix BioTherapeutics, Inc. (PLX) - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - April 1 at 8:59 PM
News IconCould Protalix BioTherapeutics Inc. Recover After Forming a Multiple Bottom Pattern? - RiversideGazette.com (NYSE:PLX)
www.riversidegazette.com - April 1 at 8:59 PM
biz.yahoo.com logoPROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F (NYSE:PLX)
biz.yahoo.com - April 1 at 5:02 PM
News IconAfter Last Week What Do Analysts Think Of Protalix BioTherapeutics, Inc. (PLX) - Share Trading News (NYSE:PLX)
www.sharetrading.news - March 28 at 7:56 PM
News IconOpaleye Management buys $7 Million stake in Protalix BioTherapeutics (PLX) - Everything HUDSON (NYSE:PLX)
www.everythinghudson.com - March 24 at 8:58 PM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Sellers Increased By 6.83% Their Shorts - Stock Caller (NYSE:PLX)
www.stockcaller.com - March 24 at 8:58 PM
clintongazette.com logoProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Shorted Shares Increased 6.83% After Market Selling - Clinton Financial (NYSE:PLX)
www.clintongazette.com - March 21 at 12:02 AM
News IconProtalix BioTherapeutics Inc. (PLX) Given New $1.75 Price Target at Jefferies Group - MicroCap Magazine (NYSE:PLX)
microcapmagazine.com - March 16 at 9:46 PM
News IconPrice Target Update On Protalix BioTherapeutics, Inc. (PLX) - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - March 15 at 7:43 PM
kcregister.com logoBig Movers: Protalix BioTherapeutics (NYSEMKT:PLX), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Pacific ... - KC Register (NYSE:PLX)
www.kcregister.com - March 14 at 9:27 PM
finance.yahoo.com logoPROTALIX BIOTHERAPEUTICS, INC. Financials (NYSE:PLX)
finance.yahoo.com - March 12 at 1:04 PM
News IconProtalix BioTherapeutics, Inc. (PLX) Broker Target Changes - Share Trading News (NYSE:PLX)
www.sharetrading.news - March 11 at 8:03 PM
News IconProtalix BioTherapeutics, Inc. (PLX) New Analyst Ratings - Share Trading News (NYSE:PLX)
www.sharetrading.news - March 10 at 8:23 PM
News IconProtalix BioTherapeutics 2015 Revenue Rises, Net Loss Narrows, Sees Further Milestones in 2016 (NYSEMKT:PLX) - Sonoran Weekly Review (NYSE:PLX)
sonoranweeklyreview.com - March 8 at 8:10 PM
finance.yahoo.com logoProtalix BioTherapeutics Reports Fiscal Year 2015 Financial Results and Provides Corporate Update (NYSE:PLX)
finance.yahoo.com - March 8 at 7:33 AM
streetinsider.com logoProtalix BioTherapeutics (PLX) to Present Positive Interim Data from PRX-102 Phase 1/2 in Fabry Disease - StreetInsider.com (NYSE:PLX)
www.streetinsider.com - March 3 at 7:06 PM
nasdaq.com logoProtalix Presents Positive Six And Twelve Month Interim Clinical Data On PRX-102 (NYSE:PLX)
www.nasdaq.com - March 3 at 12:28 PM
finance.yahoo.com logo7:07 am Protalix BioTherapeutics: 'positive' interim data from phase I/II dose-ranging clinical trial of PRX-102 to be presented on March 3 (NYSE:PLX)
finance.yahoo.com - March 3 at 7:07 AM
finance.yahoo.com logoProtalix BioTherapeutics Presents Positive Six and Twelve Month Interim Clinical Data on PRX-102 for the Treatment of Fabry Disease at the 12th Annual WORLDSymposium™ 2016 (NYSE:PLX)
finance.yahoo.com - March 3 at 7:00 AM
News IconProtalix BioTherapeutics, Inc. (PLX) Broker Updates - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - March 2 at 12:16 PM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Sellers Covered 6.22% of Their Shorts - Franklin Independent (NYSE:PLX)
www.franklinindependent.com - February 26 at 7:11 PM
News IconProtalix Biotherapeutics Incorporated (NYSEMKT:PLX) Shorted Shares Decreased By 6.22% - Franklin Independent (NYSE:PLX)
www.franklinindependent.com - February 22 at 11:35 AM
finance.yahoo.com logoProtalix BioTherapeutics to Participate in the SunTrust Robinson Humphrey Orphan Drug Day and the 12th Annual WORLDSymposium™ 2016 (NYSE:PLX)
finance.yahoo.com - February 22 at 7:30 AM
News IconCould Protalix BioTherapeutics Inc. Go Down? The Stock Formed Bearish Multiple Bottom Pattern - Sonoran Weekly Review (NYSE:PLX)
sonoranweeklyreview.com - February 17 at 6:03 PM
News IconProtalix BioTherapeutics, Inc. (PLX) Price Target Changes - Risers & Fallers (NYSE:PLX)
www.risersandfallers.com - February 16 at 10:52 AM

Social

Protalix BioTherapeutics (NYSE:PLX) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff